Zdrowie i gospodarka · 16/11/1994
NIH to Consider Partially Exclusive Patent License for Ophthalmology Treatments
The National Institutes of Health (NIH) is seeking public comment on a proposed license to practice certain ophthalmology treatments, including those related to purified transforming growth factor beta, with Celtrix Pharmaceuticals Inc. of Santa Clara, California.